Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) fell 3.8% on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. 384,329 shares were traded during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Trading Down 3.8%
The company has a current ratio of 2.97, a quick ratio of 2.61 and a debt-to-equity ratio of 35.45. The stock has a 50-day simple moving average of C$0.26 and a two-hundred day simple moving average of C$0.26. The firm has a market capitalization of C$52.28 million and a P/E ratio of -0.37.
About Emerald Health Therapeutics
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.
Featured Articles
- Five stocks we like better than Emerald Health Therapeutics
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
